|
Sign In to gain access to subscriptions and/or personal tools.
|
Determining Indications for Care Common to Competing Guidelines by Using Classification Tree Analysis: Application to the Prevention of Venous Thromboembolism in Medical Inpatients
Jean-Luc Bosson, MD, PhD
Laboratoire TIMC IMAG UMR CNRS 5525, Grenoble, France.
Jose Labarere, MD
Unité d'Evaluation Medicale, Pavillon Taillefer, CHU BP 217, 38 043 Grenoble Cedex 9, FranceJLabarere{at}chu-grenoble.fr
Background. Substantial variations have been reported in the advice given by competing guidelines addressing the same clinical problem. Objective. This study aimed to assess the usefulness of classification tree analysis in comparing competing guidelines. Method. The authors implemented a classification treegrowing algorithm on cross-sectional data from 818 patients to determine indications for prophylactic heparin treatment common to 4 competing guidelines disseminated between 1998 and 2000 and addressing the prophylaxis of venous thromboembolism in medical inpatients. Results. The resulting classification tree involved 10 terminal nodes. Its mean accuracy estimated by performing 10-fold cross-validation was 82% (s = 3). The guidelines consistently supported prophylactic heparin treatment for 5 indications: a previous episode of deep vein thrombosis or pulmonary embolism, recent paralysis of lower limb(s), congestive heart failure with one or more risk factors, recent myocardial infarction, and malignancy with one or more risk factors. These indications involved 257 patients (31.4%) and were supported by robust scientific evidence. Deep vein thrombosis was detected in 27 of these patients (10.5%). Two consistent negative indications involved 347 patients (42.4%). Deep vein thrombosis was detected in 9 of these patients (2.6%). Three indications involving 214 patients (26.2%) were discordant over the 4 guidelines. Conclusion. Classification tree analysis of real patient data is a useful strategy to identify indications common to competing guidelines. These indications should be considered for inclusion when updating guidelines. The findings of recently completed randomized trials have partly resolved the disagreement among the 4 guidelines. This approach may be helpful when developing new guidelines or for identifying topics warranting further complementary clinical trials.
Key Words: guidelines data analysis venous thromboembolism prevention
References
- Woolf SH. Practice guidelines, a new reality in medicine: II. Methods of developing guidelines. Arch Intern Med. 1992;152: 946952.[Abstract/Free Full Text]
- Institute of Medicine. Guidelines for Clinical Practice: From Development to Use. Washington (DC): NationalAcademy Press; 1992.
- Hayward RS, Wilson MC, Tunis SR, Bass EB, Guyatt G. Users guides to the medical literature: VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA. 1995;274:570574.[Abstract/Free Full Text]
- Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica (CA): RAND; 2001.
- Campbell SM, Hann M, Roland MO, Quayle JA, Shekelle PG. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care. 1999;37:964968.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lomas J, Anderson G, Enkin M, Vayda E, Roberts R, MacKinnon B. The role of evidence in the consensus process. Results from a Canadian consensus exercise. JAMA. 1988;259:30013005.[Abstract/Free Full Text]
- Pearson SD, Margolis CZ, Davis S, Schreier LK, Sokol HN, Gottlieb LK. Is consensus reproducible? A study of an algorithmic guidelines development process. Med Care. 1995;33:643660.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:14581465.[Abstract/Free Full Text]
- Adams JL, Fitzmaurice DA, Heath CM, et al. A novel method of guideline development for the diagnosis andmanagement ofmild to moderate hypertension. Br J Gen Pract. 1999;49:175179.[Web of Science][Medline]
[Order article via Infotrieve]
- Pearson SD, Margolis CZ, Davis S, Schreier LK, Gottlieb LK. The clinical algorithm nosology: a method for comparing algorithmic guidelines. Med Decis Making. 1992;12:123131.[Abstract/Free Full Text]
- Anderson FA, Wheeler HB, Goldberg RJ, et al. A populationbased perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933938.[Abstract/Free Full Text]
- Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164: 963968.[Abstract/Free Full Text]
- Thilly N, Pierson H, Collard C, Lecompte T, Dufay E. Prophylaxis of venous thromboembolism inmedical patients: from medical decision tools to the use of low molecular weight heparin [in French]. Therapie. 1998;53:579586.[Web of Science][Medline]
[Order article via Infotrieve]
- Fagot JP, Flahault A, Kanfer A, et al. Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin [in French]. Presse Med. 2000;29:410.[Web of Science][Medline]
[Order article via Infotrieve]
- Bergmann J, Mahe I. Prevention of venous thromboembolism in medical patients [in French]. Ann Med Interne. 2000;151:207214.[Medline]
[Order article via Infotrieve]
- Labarere J, Bosson JL, Brion JP, et al. Validation of a clinical guideline on prevention of venous thromboembolism in medical inpatients: a before-and-after study with systematic ultrasound examination. J Intern Med. 2004;256:338348.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Labarere J, Bosson JL, Bergmann JF, Thilly N. Agreement of four competing guidelines on prevention of venous thromboembolism and comparisonwith observed physician practices: a cross-sectional study of 1,032 medical inpatients. J Gen Intern Med. 2004;19:849855.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bosson JL, Labarere J, Sevestre MA, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med. 2003;163:26132618.[Abstract/Free Full Text]
- Fagot JP, Flahault A, Fodil M, et al. Prophylactic prescription of low-molecular-weight heparin in the non-surgical setting: impact of recommendations [in French]. Presse Med. 2001;30:203208.[Web of Science][Medline]
[Order article via Infotrieve]
- Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. New York: Chapman & Hall; 1984.
- Quinlan JR. C4.5: Programs for Machine Learning. San Mateo (CA): Morgan Kaufman; 1993.
- Shannon CE. A mathematical theory of communication. Bell System Tech J. 1948;27:379423.
- Gray-Donald K, Kramer MS. Causality inference in observational vs. experimental studies. An empirical comparison. Am J Epidemiol. 1988;127:885892.[Free Full Text]
- Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ. 1992;305:567574.[Free Full Text]
- Woodhead M. Community-acquired pneumonia guidelinesan international comparison: a view from Europe. Chest. 1998;113: 183S187S.[Abstract/Free Full Text]
- Barak N, Margolis CZ, Gottlieb LK. Text-to-algorithm conversion to facilitate comparison of competing clinical guidelines. Med Decis Making. 1998;18:304310.[Abstract/Free Full Text]
- Boxwala AA, Tu S, Peleg M, et al. Toward a representation format for sharable clinical guidelines. J Biomed Inform. 2001;34:157169.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Shiffman RN, Greenes RA. Improving clinical guidelines with logic and decision-table techniques: application to hepatitis immunization recommendations. Med Decis Making. 1994;14:245254.[Abstract/Free Full Text]
- Marshall RJ. Aprogram to implement a search method for identification of clinical subgroups. Stat Med. 1995;14:26452659.[Web of Science][Medline]
[Order article via Infotrieve]
- Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:483S512S.[Abstract/Free Full Text]
- Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic andThrombolytic Therapy. Chest. 2004;126:338S400S.[Abstract/Free Full Text]
- Buller HR, Agnelli G, Hull RD, Hyers TM, PrinsMH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401S428S.[Abstract/Free Full Text]
- Menon V, Harrington RA, Hochman JS, et al. Thrombolysis and adjunctive therapy in acute myocardial infarction: the SeventhACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:549S575S.[Abstract/Free Full Text]
- Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874879.[Abstract/Free Full Text]
- Bergmann JF, Caulin C. Heparin prophylaxis in bedridden patients. Lancet. 1996;348:205206.[Web of Science][Medline]
[Order article via Infotrieve]
- Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet. 1996; 347:13571361.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fielding JE, Lancry PJ. Lessons fromFrancevive la difference. The French health care system and US health system reform. JAMA. 1993;270:748756.[Abstract/Free Full Text]
- Bernstein SJ, Lazaro P, Fitch K, Aguilar MD, Kahan JP. Effect of specialty and nationality on panel judgments of the appropriateness of coronary revascularization: a pilot study. Med Care. 2001;39: 513520.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wietlisbach V, Vader JP, Porchet F, CostanzaMC, Burnand B. Statistical approaches in the development of clinical practice guidelines from expert panels: the case of laminectomy in sciatica patients. Med Care. 1999;37:785797.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Thomson R, McElroy H, SudlowM. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ. 1998;316:509513.[Abstract/Free Full Text]
- Marshall RJ. The use of classification and regression trees in clinical epidemiology. J Clin Epidemiol. 2001;54:603609.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Esposito F, Malerba D, Semeraro G. A comparative analysis of methods for pruning decision trees. IEEETrans Pattern AnalMachine Intel. 1997;19:476491.[CrossRef]
- Mingers J. An empirical comparison of pruning methods for decision tree induction. Machine Learn. 1989;4:227243.
- Dhôte R, Pellicier-CoeuretM, Belouet-Moreau C, Christoforov B, Vidal-Trecan G. Venous thromboembolism in medical inpatients: prophylaxis with low-weight heparin in a university hospital and prevalence of thromboembolic events. Clin Appl Thromb Hemost. 2001;7:1620.[Web of Science][Medline]
[Order article via Infotrieve]
Medical Decision Making, Vol. 26, No. 1,
63-75 (2006)
DOI: 10.1177/0272989X05284105

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Helfand and L. Saxton
Medical Decision Making and Electronic Publishing
Med Decis Making,
March 1, 2007;
27(2):
98 - 100.
[PDF]
|
 |
|
|
|